Therapeutic Effects of Rho Kinase Inhibitor on Experimental Diabetic Neuropathy

被引：0
|
作者：
Kanazawa, Yasushi
Utsunomiya, Kazunori
Ishizawa, Shou
Matoba, Keiichiro
Gojo, Atsushi
Yokota, Tamotsu
Kurata, Hideaki
Tajima, Naoko
Fujigasaki, Junko
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A228 / A228
页数：1
相关论文
共 50 条
  • [21] Discordant effects of two PARP inhibitor-containing combination therapies in experimental diabetic neuropathy
    Li, F
    Charniauskaya, T
    Abatan, OI
    Stevens, MJ
    Obrosova, IG
    DIABETES, 2004, 53 : A212 - A212
  • [22] The effect of rho-kinase inhibitor fasudil in experimental autoimmune neuritis
    Pineda, Arnold Angelo M.
    Minohara, Motozumi
    Sun, Xiaojia
    Ishizu, Takaaki
    Shimokawa, Hiroaki
    Kira, Jun-ichi
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 57 - 58
  • [23] The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats
    Gojo, Atsushi
    Utsunomiya, Kazunori
    Taniguchi, Kanta
    Yokota, Tamotsu
    Ishizawa, Shoh
    Kanazawa, Yasushi
    Kurata, Hideaki
    Tajima, Naoko
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 568 (1-3) : 242 - 247
  • [24] The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy
    Quillen, Sarah E.
    Kimball, Elizabeth C.
    Ritter-Gordy, Kelsey A.
    Du, Liya
    Yuan, Zhuochen
    Pease, Mary E.
    Madhoun, Salaheddine
    Nguyen, Thao D.
    Johnson, Thomas V.
    Quigley, Harry A.
    Pitha, Ian F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (13)
  • [25] Effect of a protein kinase C-β specific inhibitor on diabetic neuropathy in rats
    Nakamura, J
    Koh, N
    Hamada, Y
    Naruse, K
    Chaya, S
    Kato, K
    Ienaga, K
    Hotta, N
    DIABETES, 1998, 47 : A70 - A70
  • [26] Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat
    Y. Kuzumoto
    S. Kusunoki
    N. Kato
    M. Kihara
    P. A. Low
    Diabetologia, 2006, 49
  • [27] EXPERIMENTAL AND CLINICAL-TRIAL OF ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HOTTA, N
    KAKUTA, H
    KIMURA, M
    FUKASAWA, H
    KOH, N
    TERASHIMA, H
    IIDA, M
    SAKAMOTO, N
    DIABETES, 1983, 32 : A98 - A98
  • [28] Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat
    Kuzumoto, Y.
    Kusunoki, S.
    Kato, N.
    Kihara, M.
    Low, P. A.
    DIABETOLOGIA, 2006, 49 (12) : 3085 - 3093
  • [29] Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis
    Okamoto, H
    Nomura, M
    Nakaya, Y
    Uehara, K
    Saito, K
    Kimura, M
    Chikamori, K
    Ito, S
    INTERNAL MEDICINE, 2003, 42 (08) : 655 - 664
  • [30] EXPERIMENTAL DIABETIC NEUROPATHY
    MOORE, SA
    OCONNOR, BL
    PETERSON, RG
    ANATOMICAL RECORD, 1979, 193 (03): : 627 - 627
12345